Atlas Trials

Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response

Clinical trial NCT03609099 · UNKNOWN

Trial details

NCT number
NCT03609099
Sponsor
David Garcia Cinca
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Community-acquired Pneumonia
Start date
2019-02-15
Primary completion
2020-11-15
Enrollment
424

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.